Thought Leadership Losing control of life transitions and how to measure its impact to drive the value of positive change
Thought Leadership John McConnell answers the pharmaceutical industry’s questions on the future impact of COVID-19 on the healthcare landscape
Thought Leadership Optimising patient pathways in rare disease through and beyond the COVID-19 pandemic
Thought Leadership Solving 5 common challenges in transitioning medical communications content to digital formats
Thought Leadership Disruptive listening to better engage patients in research: highlights from the Patients as Partners Europe Virtual Conference
Thought Leadership Losing control of life transitions in rare disease – 3 reasons to give this a listen